Patents by Inventor LAURA SAUNDERS

LAURA SAUNDERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-BMPR1B ANTIBODIES AND METHODS OF USE
    Publication number: 20210261670
    Abstract: Provided are novel anti-BMPR1B antibodies and antibody drug conjugates, and methods of using such anti-BMPR1B antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: January 29, 2021
    Publication date: August 26, 2021
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SOMDUTTA ROY, LAURA SAUNDERS, CASEY FRANKLIN, KEVIN MARTINEZ, SARAH FONG, ZHAO HUANG, SILVIA JUAREZ, ALINA HE, KATHRYN A. LOVING, SANDRO VIVONA
  • Light chain variable regions
    Patent number: 11033634
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: June 15, 2021
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-BMPR1B antibodies and methods of use
    Patent number: 10934359
    Abstract: Provided are novel anti-BMPR1B antibodies and antibody drug conjugates, and methods of using such anti-BMPR1B antibodies and antibody drug conjugates to treat cancer.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: March 2, 2021
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Somdutta Roy, Laura Saunders, Casey Franklin, Kevin Martinez, Sarah Fong, Zhao Huang, Silvia Juarez, Alina He, Kathryn A. Loving, Sandro Vivona
  • ANTI SEZ6 ANTIBODIES AND METHODS OF USE
    Publication number: 20200181256
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: December 12, 2019
    Publication date: June 11, 2020
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, ROBERT A. STULL, MICHAEL TORGOV, HUI SHAO, DAVID LIU
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20200138969
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: December 6, 2019
    Publication date: May 7, 2020
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti SEZ6 antibodies and methods of use
    Patent number: 10533051
    Abstract: Provided are novel seizure related 6 (SEZ6) modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: January 14, 2020
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Laura Saunders, Scott J. Dylla, Orit Foord, Robert A. Stull, Michael Torgov, Hui Shao, David Liu
  • Anti-MFI2 antibodies and methods of use
    Patent number: 10428156
    Abstract: Provided are novel anti-MFI2 antibodies and antibody drug conjugates, and methods of using such anti-MFI2 antibodies and antibody drug conjugates to treat cancer.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: October 1, 2019
    Assignee: Abbvie Stemcentrx LLC
    Inventors: Samuel Williams, Laura Saunders, Holger Karsunky, Mandy Boontanrart
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20190247510
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: April 12, 2019
    Publication date: August 15, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
    Publication number: 20190225685
    Abstract: Provided are novel anti-DLL3 antibodies and antibody drug conjugates, and methods of using such anti-DLL3 antibodies and antibody drug conjugates to treat brain cancer.
    Type: Application
    Filed: January 24, 2019
    Publication date: July 25, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: KUMIKO ISSE, LAURA SAUNDERS
  • ANTI-DLL3 DRUG CONJUGATES FOR TREATING TUMORS AT RISK OF NEUROENDOCRINE TRANSITION
    Publication number: 20190201542
    Abstract: Methods of treating tumors at risk for neuroendocrine transition using anti-delta-like ligand 3 (DLL3) antibody drug conjugates (ADCs) are provided.
    Type: Application
    Filed: May 19, 2017
    Publication date: July 4, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Laura SAUNDERS, Robert A. STULL, Daniel R. HYDUKE, Enying YOU
  • ANTI-ASCL1 ANTIBODIES AND METHODS OF USE
    Publication number: 20190194319
    Abstract: Compositions comprising Achaete-scute homolog 1 (ASCL1) antibodies, and methods comprising ASCL1 antibody compositions for detecting ASCL1 expression as a diagnostic biomarker, are provided.
    Type: Application
    Filed: May 19, 2017
    Publication date: June 27, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JEFFREY BERNSTEIN, LAURA SAUNDERS, SHEILA BHEDDAH, ENYING YOU, CASEY FRANKLIN, TIEN YIN YAU, GRAYSON KOCHI
  • Anti-DLL3 antibodies and drug conjugates for use in melanoma
    Patent number: 10308721
    Abstract: Anti-DLL3 antibodies and antibody drug conjugates for use in the diagnosis and treatment of melanoma.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: June 4, 2019
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Samuel Williams, Laura Saunders, Kathryn A Loving
  • NOVEL ANTI-BMPR1B ANTIBODIES AND METHODS OF USE
    Publication number: 20190153103
    Abstract: Provided are novel anti-BMPR1B antibodies and antibody drug conjugates, and methods of using such anti-BMPR1B antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: April 21, 2017
    Publication date: May 23, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SOMDUTTA ROY, LAURA SAUNDERS, CASEY FRANKLIN, KEVIN MARTINEZ, SARAH FONG, ZHAO HUANG, SILVIA JUAREZ, ALINA HE, KATHRYN A. LOVING, SANDRO VIVONA
  • NOVEL ANTI-TNFRSF21 ANTIBODIES AND METHODS OF USE
    Publication number: 20190127476
    Abstract: Provided are novel anti-TNFRSF21 antibodies and antibody drug conjugates, and methods of using such anti-TNFRSF21 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 2, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, DEEPTI ROKKAM, DAVID LIU, MANDY BOONTANRART, ALEXANDER JOHN BANKOVICH, EVAN BISHOP, MONETTE AUJAY, ZHAO HUANG
  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20190077876
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: August 20, 2018
    Publication date: March 14, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Marianne SANTAGUIDA, Monette AUJAY, Laura SAUNDERS, David LIU, Orit FOORD, Robert A. STULL, Paul Anthony ESCARPE
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20190046656
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: October 25, 2018
    Publication date: February 14, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DPEP3 antibodies and methods of use
    Patent number: 10189910
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: January 29, 2019
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Laura Saunders, Deepti Rokkam, David Liu, Mandy Boontanrart
  • NOVEL SEZ6 MODULATORS AND METHODS OF USE
    Publication number: 20190022241
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: June 11, 2018
    Publication date: January 24, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: David Liu, Deepti Rokkam, Sheila Bheddah, Javier Lopez-Molina, Laura Saunders
  • NOVEL ANTI-MMP16 ANTIBODIES AND METHODS OF USE
    Publication number: 20190022242
    Abstract: Provided are novel anti-MMP16 antibodies and antibody drug conjugates, and methods of using such anti-MMP16 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 24, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: SOMDUTTA ROY, SAMUEL A. WILLIAMS, SCOTT J. DYLLA, ZHAO HUANG, LAURA SAUNDERS, DAVID LIU, CASEY FRANKLIN, DAVID COELHO
  • NOVEL ANTI-TNFSF9 ANTIBODIES AND METHODS OF USE
    Publication number: 20190016812
    Abstract: Provided are novel anti-TNFSF9 antibodies and antibody drug conjugates, and methods of using such anti-TNFSF9 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 17, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: JEFFREY BERNSTEIN, DAVID COELHO, LAURA SAUNDERS, AMY LAYSANG, SAMUEL A, WILLIAMS, DAVID LIU, EARL KIM, ROBERT A. STULL